Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Horse ATG/CsA vs Rabbit ATG/CsA vs Alemtuzumab in SAA
NCT00260689Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Nov 2005
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, alemtuzumab in aplastic anemia, sponsored by National Heart, Lung, and Blood Institute. Started Nov 2005; status: completed.
02
Drugs
antithymocyte globulin rabbitalemtuzumab
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT00260689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260689.